Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
28
DTEAF Quote, Financials, Valuation and Earnings
Last price:
$0.79
Seasonality move
:
7.95%
Day range:
$0.76 - $0.80
52-week range:
$0.08 - $0.88
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.30x
P/B ratio:
0.77x
Volume:
18.9K
Avg. volume:
25.8K
1-year change:
375.98%
Market cap:
$21.3M
Revenue:
--
EPS (TTM):
--
Earnings Data
Next earnings date for DTEAF
Sep 17
2025
Most recent earnings per share
-$0.14
Missed by $0.14
(Oct 31/2022)
Consensus Estimate
--
(Oct 31/2022)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
DTEAF Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 10/31/2022 | Q4 | -- | $12.2M | -$0.14 | -- | -- |
| 09/13/2022 | Q3 | -- | $11.8M | -$0.14 | -- | -- |
| 04/30/2022 | Q2 | -- | $16.1M | -$0.06 | -- | -- |
| 01/31/2022 | Q1 | -- | $31.5M | $0.03 | -- | -- |
| 10/31/2021 | Q4 | -- | $17.7M | -$0.06 | -- | -- |
| 07/31/2021 | Q3 | -- | $15.3M | $2.24 | -- | -- |
| 04/30/2021 | Q2 | -- | $18.5M | $0.10 | -- | -- |
| 01/31/2021 | Q1 | -- | $31.2M | -$0.81 | -- | -- |
| 10/31/2020 | Q4 | -- | $19.8M | $0.41 | -- | -- |
| 07/31/2020 | Q3 | -- | $16.8M | $0.07 | -- | -- |
| 04/30/2020 | Q2 | -- | $23.5M | -$1.28 | -- | -- |
| 01/31/2020 | Q1 | -- | $55.9M | -$0.17 | -- | -- |
| 10/31/2019 | Q4 | -- | $29.8M | -$0.32 | -- | -- |
| 07/31/2019 | Q3 | -- | $29.5M | -$0.33 | -- | -- |
| 04/30/2019 | Q2 | -- | $33.2M | -$0.10 | -- | -- |
| 01/31/2019 | Q1 | -- | $62.4M | -$0.38 | -- | -- |
| 10/31/2018 | Q4 | -- | $33.5M | -$0.27 | -- | -- |
| 07/31/2018 | Q3 | -- | $30.8M | -$0.30 | -- | -- |
| 04/30/2018 | Q2 | -- | $36M | -$0.04 | -- | -- |
| 01/31/2018 | Q1 | -- | $68.5M | -$0.49 | -- | -- |
| 10/31/2017 | Q4 | -- | $34.4M | -$0.20 | -- | -- |
| 07/31/2017 | Q3 | -- | $34.6M | -$0.17 | -- | -- |
| 04/30/2017 | Q2 | -- | $36.6M | -$0.01 | -- | -- |
| 01/31/2017 | Q1 | -- | $64.7M | $0.06 | -- | -- |
| 10/31/2016 | Q4 | -- | $33.7M | -$0.15 | -- | -- |
| 07/31/2016 | Q3 | -- | $31.7M | -$0.07 | -- | -- |
| 04/30/2016 | Q2 | -- | $33.4M | $0.05 | -- | -- |
| 01/31/2016 | Q1 | -- | $55.2M | $0.42 | -- | -- |
| 10/31/2015 | Q4 | -- | $27.6M | -$0.03 | -- | -- |
| 07/31/2015 | Q3 | -- | $26.3M | -$2.19 | -- | -- |
DAVIDsTEA Earnings Questions
-
How Much did DAVIDsTEA Generate in Revenue Last Quarter?
DAVIDsTEA reported $12.2M worth of top line sales in its most recent quarter.
-
Did DAVIDsTEA Beat Earnings Last Quarter?
DAVIDsTEA announced earnings per share of -$0.14 which represents a miss of analyst forecast a -- per share.
-
Is DAVIDsTEA Profitable?
DAVIDsTEA reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for DAVIDsTEA EPS Next Year?
DAVIDsTEA's earnings are forecast to grow from -- per share to -- per share next year representing an increase of --.
-
When is DAVIDsTEA's Earnings Date?
DAVIDsTEA's next earnings date is September 17, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
